These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30118192)

  • 1. Design, synthesis, and evaluation of novel diphenyl ether derivatives against drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis.
    Kar SS; Bhat VG; Shenoy VP; Bairy I; Shenoy GG
    Chem Biol Drug Des; 2019 Jan; 93(1):60-66. PubMed ID: 30118192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design and synthesis of novel diphenyl ether derivatives as antitubercular agents.
    Kar SS; Bhat G V; Rao PP; Shenoy VP; Bairy I; Shenoy GG
    Drug Des Devel Ther; 2016; 10():2299-310. PubMed ID: 27486307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and evaluation of novel molecules with a diphenyl ether nucleus as potential antitubercular agents.
    Yang Y; Wang Z; Yang J; Yang T; Pi W; Ang W; Lin Y; Liu Y; Li Z; Luo Y; Wei Y
    Bioorg Med Chem Lett; 2012 Jan; 22(2):954-7. PubMed ID: 22197389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones.
    Li P; Wang B; Zhang X; Batt SM; Besra GS; Zhang T; Ma C; Zhang D; Lin Z; Li G; Huang H; Lu Y
    Eur J Med Chem; 2018 Dec; 160():157-170. PubMed ID: 30336450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting fatty acid biosynthesis for the development of novel chemotherapeutics against Mycobacterium tuberculosis: evaluation of A-ring-modified diphenyl ethers as high-affinity InhA inhibitors.
    Boyne ME; Sullivan TJ; amEnde CW; Lu H; Gruppo V; Heaslip D; Amin AG; Chatterjee D; Lenaerts A; Tonge PJ; Slayden RA
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3562-7. PubMed ID: 17664324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
    Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, in silico and in vitro evaluation of novel diphenyl ether derivatives as potential antitubercular agents.
    Tiwari AP; Sridhar B; Boshoff HI; Arora K; Gautham Shenoy G; Vandana KE; Varadaraj Bhat G
    Mol Divers; 2020 Nov; 24(4):1265-1279. PubMed ID: 31506871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of 1H-1,2,3-triazoles derived from econazole as antitubercular agents.
    Kim S; Cho SN; Oh T; Kim P
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6844-7. PubMed ID: 23058885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitubercular activity of heterocycle substituted diphenyl ether derivatives.
    Kini SG; Bhat A; Pan Z; Dayan FE
    J Enzyme Inhib Med Chem; 2010 Oct; 25(5):730-6. PubMed ID: 20443682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis, and Biological Evaluation of 1,4-dihydropyridine Derivatives as Potent Antitubercular Agents.
    Desai NC; Trivedi AR; Somani HC; Bhatt KA
    Chem Biol Drug Des; 2015 Sep; 86(3):370-7. PubMed ID: 25534154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis of benzocoumarin-pyrimidine hybrids as novel class of antitubercular agents, their DNA cleavage and X-ray studies.
    Reddy DS; Hosamani KM; Devarajegowda HC
    Eur J Med Chem; 2015 Aug; 101():705-15. PubMed ID: 26210508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and docking studies of some novel (R)-2-(4'-chlorophenyl)-3-(4'-nitrophenyl)-1,2,3,5-tetrahydrobenzo[4,5] imidazo [1,2-c]pyrimidin-4-ol derivatives as antitubercular agents.
    Barot KP; Jain SV; Gupta N; Kremer L; Singh S; Takale VB; Joshi K; Ghate MD
    Eur J Med Chem; 2014 Aug; 83():245-55. PubMed ID: 24972340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and biological evaluation of novel isoniazid derivatives with potent antitubercular activity.
    Martins F; Santos S; Ventura C; Elvas-Leitão R; Santos L; Vitorino S; Reis M; Miranda V; Correia HF; Aires-de-Sousa J; Kovalishyn V; Latino DA; Ramos J; Viveiros M
    Eur J Med Chem; 2014 Jun; 81():119-38. PubMed ID: 24836065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents.
    Penta A; Franzblau S; Wan B; Murugesan S
    Eur J Med Chem; 2015 Nov; 105():238-44. PubMed ID: 26498570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents.
    Borsoi AF; Paz JD; Abbadi BL; Macchi FS; Sperotto N; Pissinate K; Rambo RS; Ramos AS; Machado D; Viveiros M; Bizarro CV; Basso LA; Machado P
    Eur J Med Chem; 2020 Apr; 192():112179. PubMed ID: 32113048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary SAR and biological evaluation of antitubercular triazolothiadiazine derivatives against drug-susceptible and drug-resistant Mtb strains.
    Li Z; Bai X; Deng Q; Zhang G; Zhou L; Liu Y; Wang J; Wang Y
    Bioorg Med Chem; 2017 Jan; 25(1):213-220. PubMed ID: 27810439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preliminary structure-activity relationships and biological evaluation of novel antitubercular indolecarboxamide derivatives against drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
    Onajole OK; Pieroni M; Tipparaju SK; Lun S; Stec J; Chen G; Gunosewoyo H; Guo H; Ammerman NC; Bishai WR; Kozikowski AP
    J Med Chem; 2013 May; 56(10):4093-103. PubMed ID: 23611124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of novel 4H-chromen-4-one derivatives as antituberculosis agents against multidrug-resistant tuberculosis.
    Zhao W; Wang B; Liu Y; Fu L; Sheng L; Zhao H; Lu Y; Zhang D
    Eur J Med Chem; 2020 Mar; 189():112075. PubMed ID: 31986405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel (-)-Camphene-based thiosemicarbazones and evaluation of anti-
    Souza MRP; Coelho NP; Baldin VP; Scodro RBL; Cardoso RF; da Silva CC; Vandresen F
    Nat Prod Res; 2019 Dec; 33(23):3372-3377. PubMed ID: 29792346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.